Latest filing published 20 Apr 2012 for SERACARE LIFE SCIENCES INC.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Kathleen Benjamin appears in our data through filings on Seracare Life Sciences Inc shares, published by SEC (Form 4). In total, 12 filings cover trades dated from 17 May 2007 to 20 April 2012.
No open-market sale appears; the market trades are 1 purchase worth €162. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 10 share grants.
The newest entry dates from 20 April 2012: a transaction, in Seracare Life Sciences Inc. The latest purchase dates back some time: it was published 7,100 days ago, on 17 May 2007. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations